Matthew Gline
CEO at Roivant Sciences Ltd. (ROIV)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $46.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 20SEC | ROIVRoivant Sciences Ltd. | Sell | 289,77416,736,116 held (−2%) | $29.16 | $8.4M | +21.5% |
| Dec 17SEC | ROIVRoivant Sciences Ltd. | Sell | 230,35717,290,820 held (−1%) | $21.68 | $5.0M | +63.5% |
| Dec 17SEC | ROIVRoivant Sciences Ltd. | Sell | 566,11618,084,676 held (−3%) | $21.68 | $12.3M | +63.5% |
| Dec 17SEC | ROIVRoivant Sciences Ltd. | Sell | 943,52718,616,406 held (−5%) | $21.68 | $20.5M | +63.5% |